UST (uronyl 2-sulfotransferase) is a sulfotransferase enzyme that catalyzes the transfer of sulfo groups to the 2-OH position of uronyl residues in glycosaminoglycan chains using 3'-phospho-5'-adenylyl sulfate (PAPS) as a sulfate donor 12. The enzyme exhibits substrate specificity, showing high activity toward iduronyl residues in dermatan sulfate and glucuronyl residues in chondroitin sulfate, while displaying minimal activity toward heparin or heparosan derivatives 12. UST localizes to the Golgi membrane where it participates in glycosaminoglycan biosynthesis, specifically contributing to dermatan sulfate and chondroitin sulfate proteoglycan production. This sulfation is critical for the structural and functional properties of extracellular matrix components. Mutations or dysregulation of UST activity would be expected to impact the sulfation patterns of these essential proteoglycans, potentially affecting cell signaling, tissue integrity, and extracellular matrix organization. However, the provided abstracts contain no information regarding UST gene mutations, disease associations, or clinical significance in human pathology, limiting comprehensive assessment of disease relevance and clinical applications.